Literature DB >> 28932926

Donor Indocyanine Green Clearance Test Predicts Graft Quality and Early Graft Prognosis After Liver Transplantation.

Yunhua Tang1,2,3, Ming Han1,2,3, Maogen Chen1,2,3, Xiaoping Wang1,2,3, Fei Ji1,2,3, Qiang Zhao1,2,3, Zhiheng Zhang1,2,3, Weiqiang Ju1,2,3, Dongping Wang1,2,3, Zhiyong Guo4,5,6, Xiaoshun He7,8,9.   

Abstract

BACKGROUND: Transplantation centers have given much attention to donor availability. However, no reliable quantitative methods have been employed to accurately assess graft quality before transplantation. Here, we report that the indocyanine green (ICG) clearance test is a valuable index for liver grafts.
METHODS: We performed the ICG clearance test on 90 brain-dead donors within 6 h before organ procurement between March 2015 and November 2016. We also analyzed the relationship between graft liver function and early graft survival after liver transplantation (LT).
RESULTS: Our results suggest that the ICG retention rate at 15 min (ICGR15) of donors before procurement was independently associated with 3-month graft survival after LT. The best donor ICGR15 cutoff value was 11.0%/min, and we observed a significant increase in 3-month graft failure among patients with a donor ICGR15 above this value. On the other hand, a donor ICGR15 value of ≤ 11.0%/min could be used as an early assessment index of graft quality because it provides additional information to the transplant surgeon or organ procurement organization members who must maintain or improve organ function to adapt the LT.
CONCLUSION: An ICG clearance test before liver procurement might be an effective quantitative method to predict graft availability and improve early graft prognosis after LT.

Entities:  

Keywords:  Graft quality; Indocyanine green clearance test; Liver transplantation

Mesh:

Substances:

Year:  2017        PMID: 28932926     DOI: 10.1007/s10620-017-4765-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Intraoperative ICG plasma disappearance rate helps to predict absence of early postoperative complications after orthotopic liver transplantation.

Authors:  J J Vos; T W L Scheeren; D J Lukes; M T de Boer; H G D Hendriks; J K G Wietasch
Journal:  J Clin Monit Comput       Date:  2013-05-16       Impact factor: 2.502

2.  Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation.

Authors:  K Singbartl; R Murugan; A M Kaynar; D W Crippen; S A Tisherman; K Shutterly; S A Stuart; R Simmons; J M Darby
Journal:  Am J Transplant       Date:  2011-03-30       Impact factor: 8.086

3.  Clearance of indocyanine green in the evaluation of liver donors.

Authors:  B Koneru; C B Leevy; K M Klein; P Zweil
Journal:  Transplantation       Date:  1994-09-27       Impact factor: 4.939

4.  Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.

Authors:  Samir G Sakka; Konrad Reinhart; Andreas Meier-Hellmann
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

Review 5.  Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy.

Authors:  Sheung-Tat Fan
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

6.  Perioperative hemodynamic study of patients undergoing abdominal surgery using pulse dye densitometry.

Authors:  Masanori Nishioka; Masashi Ishikawa; Norikazu Hanaki; Yutaka Kashiwagi; Hisashi Miki; Hidenori Miyake; Seiki Tashiro
Journal:  Hepatogastroenterology       Date:  2006 Nov-Dec

7.  Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation.

Authors:  E Levesque; E Hoti; D Azoulay; R Adam; D Samuel; D Castaing; F Saliba
Journal:  Clin Transplant       Date:  2011 Mar-Apr       Impact factor: 2.863

8.  Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.

Authors:  Eric Levesque; Faouzi Saliba; Sonia Benhamida; Philippe Ichaï; Daniel Azoulay; René Adam; Denis Castaing; Didier Samuel
Journal:  Liver Transpl       Date:  2009-10       Impact factor: 5.799

9.  Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation.

Authors:  Luis Olmedilla; José María Pérez-Peña; Cristina Ripoll; Ignacio Garutti; Roberto de Diego; Magdalena Salcedo; Consuelo Jiménez; Rafael Bañares
Journal:  Liver Transpl       Date:  2009-10       Impact factor: 5.799

10.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more
  3 in total

1.  Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.

Authors:  Vittorio Cherchi; Luigi Vetrugno; Giovanni Terrosu; Victor Zanini; Marco Ventin; Riccardo Pravisani; Francesco Tumminelli; Pier Paolo Brollo; Erica Boscolo; Roberto Peressutti; Dario Lorenzin; Tiziana Bove; Andrea Risaliti; Umberto Baccarani
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

Review 2.  Advantages of using indocyanine green in liver transplantation: a narrative review.

Authors:  Bo Dai; Nida El Islem Guissi; Lydia Frenzel Sulyok; Mitchell G Bryski; Yiqing Wang; Dongjin Wang; Sunil Singhal; Huiming Cai
Journal:  Ann Transl Med       Date:  2022-01

3.  Indocyanine green clearance test in liver transplantation: defining cut-off levels for graft viability assessment during organ retrieval and for the prediction of post-transplant graft function recovery - the Liver Indocyanine Green (LivInG) Trial Study Protocol.

Authors:  Alessandro Coppola; Giuseppe Bianco; Quirino Lai; Giuseppe Marrone; Miriam Caimano; Salvatore Agnes; Gabriele Spoletini
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.